SUMMARYDifferent observations concerning the duration of the neuromuscular blocking effect of tubocurarine in patients with renal failure have been rationalized by pharmacokinetic analysis. Computer simulations predict that absence of renal function will have little effect on the duration of action of relatively small single doses of tubocurarine but that the duration of action of large single doses and multiple doses will be prolonged significantly.